nodes	percent_of_prediction	percent_of_DWPC	metapath
Pilocarpine—CYP2A6—Arformoterol—chronic obstructive pulmonary disease	0.105	0.138	CbGbCtD
Pilocarpine—CYP2A6—Formoterol—chronic obstructive pulmonary disease	0.105	0.138	CbGbCtD
Pilocarpine—CHRM3—Tiotropium—chronic obstructive pulmonary disease	0.101	0.132	CbGbCtD
Pilocarpine—CHRM1—Tiotropium—chronic obstructive pulmonary disease	0.0877	0.115	CbGbCtD
Pilocarpine—CHRM2—Tiotropium—chronic obstructive pulmonary disease	0.0809	0.106	CbGbCtD
Pilocarpine—CYP2A6—Montelukast—chronic obstructive pulmonary disease	0.0798	0.104	CbGbCtD
Pilocarpine—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0591	0.0773	CbGbCtD
Pilocarpine—CYP2A6—Prednisolone—chronic obstructive pulmonary disease	0.0468	0.0612	CbGbCtD
Pilocarpine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0278	0.0363	CbGbCtD
Pilocarpine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0188	0.0245	CbGbCtD
Pilocarpine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0179	0.0234	CbGbCtD
Pilocarpine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0159	0.0209	CbGbCtD
Pilocarpine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00936	0.0122	CbGbCtD
Pilocarpine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00884	0.0116	CbGbCtD
Pilocarpine—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000282	0.00142	CcSEcCtD
Pilocarpine—Hiccups—Prednisone—chronic obstructive pulmonary disease	0.00028	0.00141	CcSEcCtD
Pilocarpine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00028	0.00141	CcSEcCtD
Pilocarpine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000277	0.00139	CcSEcCtD
Pilocarpine—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.000275	0.00139	CcSEcCtD
Pilocarpine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000275	0.00139	CcSEcCtD
Pilocarpine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000275	0.00138	CcSEcCtD
Pilocarpine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000275	0.00138	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000273	0.00137	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000271	0.00137	CcSEcCtD
Pilocarpine—Cough—Formoterol—chronic obstructive pulmonary disease	0.000271	0.00137	CcSEcCtD
Pilocarpine—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000271	0.00137	CcSEcCtD
Pilocarpine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00027	0.00136	CcSEcCtD
Pilocarpine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000269	0.00136	CcSEcCtD
Pilocarpine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000269	0.00136	CcSEcCtD
Pilocarpine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000268	0.00135	CcSEcCtD
Pilocarpine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000268	0.00135	CcSEcCtD
Pilocarpine—Cough—Montelukast—chronic obstructive pulmonary disease	0.000266	0.00134	CcSEcCtD
Pilocarpine—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000265	0.00133	CcSEcCtD
Pilocarpine—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000265	0.00133	CcSEcCtD
Pilocarpine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000265	0.00133	CcSEcCtD
Pilocarpine—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000265	0.00133	CcSEcCtD
Pilocarpine—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000265	0.00133	CcSEcCtD
Pilocarpine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000265	0.00133	CcSEcCtD
Pilocarpine—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000265	0.00133	CcSEcCtD
Pilocarpine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000264	0.00133	CcSEcCtD
Pilocarpine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000264	0.00133	CcSEcCtD
Pilocarpine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000264	0.00133	CcSEcCtD
Pilocarpine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000264	0.00133	CcSEcCtD
Pilocarpine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000263	0.00133	CcSEcCtD
Pilocarpine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000262	0.00132	CcSEcCtD
Pilocarpine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000262	0.00132	CcSEcCtD
Pilocarpine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.00131	CcSEcCtD
Pilocarpine—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000259	0.00131	CcSEcCtD
Pilocarpine—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000259	0.00131	CcSEcCtD
Pilocarpine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000258	0.0013	CcSEcCtD
Pilocarpine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000258	0.0013	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000257	0.0013	CcSEcCtD
Pilocarpine—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000256	0.00129	CcSEcCtD
Pilocarpine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000256	0.00129	CcSEcCtD
Pilocarpine—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000256	0.00129	CcSEcCtD
Pilocarpine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000254	0.00128	CcSEcCtD
Pilocarpine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000254	0.00128	CcSEcCtD
Pilocarpine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000253	0.00128	CcSEcCtD
Pilocarpine—Infection—Formoterol—chronic obstructive pulmonary disease	0.000252	0.00127	CcSEcCtD
Pilocarpine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000252	0.00127	CcSEcCtD
Pilocarpine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00025	0.00126	CcSEcCtD
Pilocarpine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00025	0.00126	CcSEcCtD
Pilocarpine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00025	0.00126	CcSEcCtD
Pilocarpine—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000249	0.00126	CcSEcCtD
Pilocarpine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000249	0.00126	CcSEcCtD
Pilocarpine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000249	0.00125	CcSEcCtD
Pilocarpine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000249	0.00125	CcSEcCtD
Pilocarpine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000248	0.00125	CcSEcCtD
Pilocarpine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000248	0.00125	CcSEcCtD
Pilocarpine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000247	0.00124	CcSEcCtD
Pilocarpine—Infection—Montelukast—chronic obstructive pulmonary disease	0.000247	0.00124	CcSEcCtD
Pilocarpine—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000247	0.00124	CcSEcCtD
Pilocarpine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000246	0.00124	CcSEcCtD
Pilocarpine—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000244	0.00123	CcSEcCtD
Pilocarpine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000243	0.00123	CcSEcCtD
Pilocarpine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00024	0.00121	CcSEcCtD
Pilocarpine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000238	0.0012	CcSEcCtD
Pilocarpine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000237	0.00119	CcSEcCtD
Pilocarpine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000237	0.00119	CcSEcCtD
Pilocarpine—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000237	0.00119	CcSEcCtD
Pilocarpine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000236	0.00119	CcSEcCtD
Pilocarpine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000236	0.00119	CcSEcCtD
Pilocarpine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.00118	CcSEcCtD
Pilocarpine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000232	0.00117	CcSEcCtD
Pilocarpine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000232	0.00117	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000231	0.00117	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000231	0.00117	CcSEcCtD
Pilocarpine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000229	0.00116	CcSEcCtD
Pilocarpine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000229	0.00116	CcSEcCtD
Pilocarpine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000228	0.00115	CcSEcCtD
Pilocarpine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000228	0.00115	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000226	0.00114	CcSEcCtD
Pilocarpine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000226	0.00114	CcSEcCtD
Pilocarpine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000226	0.00114	CcSEcCtD
Pilocarpine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000226	0.00114	CcSEcCtD
Pilocarpine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000226	0.00114	CcSEcCtD
Pilocarpine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000225	0.00113	CcSEcCtD
Pilocarpine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000224	0.00113	CcSEcCtD
Pilocarpine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000223	0.00113	CcSEcCtD
Pilocarpine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000223	0.00113	CcSEcCtD
Pilocarpine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000223	0.00112	CcSEcCtD
Pilocarpine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000222	0.00112	CcSEcCtD
Pilocarpine—Injury—Prednisone—chronic obstructive pulmonary disease	0.000221	0.00111	CcSEcCtD
Pilocarpine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000221	0.00111	CcSEcCtD
Pilocarpine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00022	0.00111	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000219	0.0011	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000219	0.0011	CcSEcCtD
Pilocarpine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000219	0.0011	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000218	0.0011	CcSEcCtD
Pilocarpine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000217	0.00109	CcSEcCtD
Pilocarpine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000217	0.00109	CcSEcCtD
Pilocarpine—Pain—Formoterol—chronic obstructive pulmonary disease	0.000217	0.00109	CcSEcCtD
Pilocarpine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000217	0.00109	CcSEcCtD
Pilocarpine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000217	0.00109	CcSEcCtD
Pilocarpine—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000216	0.00109	CcSEcCtD
Pilocarpine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000215	0.00108	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000215	0.00108	CcSEcCtD
Pilocarpine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.00108	CcSEcCtD
Pilocarpine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000213	0.00107	CcSEcCtD
Pilocarpine—Pain—Montelukast—chronic obstructive pulmonary disease	0.000213	0.00107	CcSEcCtD
Pilocarpine—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000212	0.00107	CcSEcCtD
Pilocarpine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000212	0.00107	CcSEcCtD
Pilocarpine—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000211	0.00106	CcSEcCtD
Pilocarpine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000211	0.00106	CcSEcCtD
Pilocarpine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00021	0.00106	CcSEcCtD
Pilocarpine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00021	0.00106	CcSEcCtD
Pilocarpine—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.00106	CcSEcCtD
Pilocarpine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000209	0.00105	CcSEcCtD
Pilocarpine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000209	0.00105	CcSEcCtD
Pilocarpine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000209	0.00105	CcSEcCtD
Pilocarpine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000208	0.00105	CcSEcCtD
Pilocarpine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000208	0.00105	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000207	0.00105	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000207	0.00105	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000207	0.00104	CcSEcCtD
Pilocarpine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.00103	CcSEcCtD
Pilocarpine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.00103	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000203	0.00102	CcSEcCtD
Pilocarpine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000201	0.00101	CcSEcCtD
Pilocarpine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000201	0.00101	CcSEcCtD
Pilocarpine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000201	0.00101	CcSEcCtD
Pilocarpine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000201	0.00101	CcSEcCtD
Pilocarpine—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.0002	0.00101	CcSEcCtD
Pilocarpine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.0002	0.00101	CcSEcCtD
Pilocarpine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000198	0.000999	CcSEcCtD
Pilocarpine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000198	0.000998	CcSEcCtD
Pilocarpine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000198	0.000998	CcSEcCtD
Pilocarpine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000197	0.000995	CcSEcCtD
Pilocarpine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000197	0.000993	CcSEcCtD
Pilocarpine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000197	0.000992	CcSEcCtD
Pilocarpine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000196	0.00099	CcSEcCtD
Pilocarpine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000196	0.00099	CcSEcCtD
Pilocarpine—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000196	0.000989	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000196	0.000987	CcSEcCtD
Pilocarpine—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000192	0.00097	CcSEcCtD
Pilocarpine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.000955	CcSEcCtD
Pilocarpine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.000955	CcSEcCtD
Pilocarpine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000187	0.000942	CcSEcCtD
Pilocarpine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000187	0.000942	CcSEcCtD
Pilocarpine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000187	0.000941	CcSEcCtD
Pilocarpine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.000939	CcSEcCtD
Pilocarpine—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000186	0.000939	CcSEcCtD
Pilocarpine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000183	0.000923	CcSEcCtD
Pilocarpine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000182	0.000918	CcSEcCtD
Pilocarpine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000182	0.000918	CcSEcCtD
Pilocarpine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00018	0.000905	CcSEcCtD
Pilocarpine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00018	0.000905	CcSEcCtD
Pilocarpine—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000179	0.000903	CcSEcCtD
Pilocarpine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000178	0.000899	CcSEcCtD
Pilocarpine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.00089	CcSEcCtD
Pilocarpine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000176	0.000886	CcSEcCtD
Pilocarpine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000174	0.000875	CcSEcCtD
Pilocarpine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000174	0.000875	CcSEcCtD
Pilocarpine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000173	0.000871	CcSEcCtD
Pilocarpine—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000172	0.000868	CcSEcCtD
Pilocarpine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000172	0.000866	CcSEcCtD
Pilocarpine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00017	0.000857	CcSEcCtD
Pilocarpine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00017	0.000854	CcSEcCtD
Pilocarpine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000168	0.000846	CcSEcCtD
Pilocarpine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000168	0.000846	CcSEcCtD
Pilocarpine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000164	0.000828	CcSEcCtD
Pilocarpine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.000826	CcSEcCtD
Pilocarpine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000161	0.000813	CcSEcCtD
Pilocarpine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000161	0.000813	CcSEcCtD
Pilocarpine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00016	0.000806	CcSEcCtD
Pilocarpine—Rash—Formoterol—chronic obstructive pulmonary disease	0.00016	0.000806	CcSEcCtD
Pilocarpine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00016	0.000806	CcSEcCtD
Pilocarpine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00016	0.000806	CcSEcCtD
Pilocarpine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000159	0.000801	CcSEcCtD
Pilocarpine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000159	0.000801	CcSEcCtD
Pilocarpine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000159	0.0008	CcSEcCtD
Pilocarpine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.000798	CcSEcCtD
Pilocarpine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000158	0.000796	CcSEcCtD
Pilocarpine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000157	0.00079	CcSEcCtD
Pilocarpine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000157	0.000789	CcSEcCtD
Pilocarpine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000156	0.000785	CcSEcCtD
Pilocarpine—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000154	0.000778	CcSEcCtD
Pilocarpine—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000153	0.000773	CcSEcCtD
Pilocarpine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.000768	CcSEcCtD
Pilocarpine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.000761	CcSEcCtD
Pilocarpine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000151	0.000761	CcSEcCtD
Pilocarpine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.000761	CcSEcCtD
Pilocarpine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000151	0.00076	CcSEcCtD
Pilocarpine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000151	0.00076	CcSEcCtD
Pilocarpine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.000756	CcSEcCtD
Pilocarpine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.000746	CcSEcCtD
Pilocarpine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000148	0.000744	CcSEcCtD
Pilocarpine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000145	0.000733	CcSEcCtD
Pilocarpine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000721	CcSEcCtD
Pilocarpine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000142	0.000717	CcSEcCtD
Pilocarpine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000142	0.000714	CcSEcCtD
Pilocarpine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.000693	CcSEcCtD
Pilocarpine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000135	0.000681	CcSEcCtD
Pilocarpine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000134	0.000676	CcSEcCtD
Pilocarpine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000133	0.00067	CcSEcCtD
Pilocarpine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000662	CcSEcCtD
Pilocarpine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000657	CcSEcCtD
Pilocarpine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000633	CcSEcCtD
Pilocarpine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000124	0.000626	CcSEcCtD
Pilocarpine—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000626	CcSEcCtD
Pilocarpine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.000622	CcSEcCtD
Pilocarpine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.000592	CcSEcCtD
Pilocarpine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000581	CcSEcCtD
Pilocarpine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.000571	CcSEcCtD
Pilocarpine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000567	CcSEcCtD
Pilocarpine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000553	CcSEcCtD
Pilocarpine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000542	CcSEcCtD
Pilocarpine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000532	CcSEcCtD
Pilocarpine—CHRM1—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.000105	0.00279	CbGpPWpGaD
Pilocarpine—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000525	CcSEcCtD
Pilocarpine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000525	CcSEcCtD
Pilocarpine—CYP2A6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000104	0.00277	CbGpPWpGaD
Pilocarpine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000523	CcSEcCtD
Pilocarpine—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000519	CcSEcCtD
Pilocarpine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.00051	CcSEcCtD
Pilocarpine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.0001	0.00268	CbGpPWpGaD
Pilocarpine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.0001	0.00267	CbGpPWpGaD
Pilocarpine—Oedema—Prednisone—chronic obstructive pulmonary disease	9.99e-05	0.000503	CcSEcCtD
Pilocarpine—Infection—Prednisone—chronic obstructive pulmonary disease	9.92e-05	0.0005	CcSEcCtD
Pilocarpine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	9.91e-05	0.00265	CbGpPWpGaD
Pilocarpine—CYP2E1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.84e-05	0.00263	CbGpPWpGaD
Pilocarpine—Shock—Prednisone—chronic obstructive pulmonary disease	9.82e-05	0.000495	CcSEcCtD
Pilocarpine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	9.75e-05	0.000491	CcSEcCtD
Pilocarpine—CYP2E1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.71e-05	0.00259	CbGpPWpGaD
Pilocarpine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	9.65e-05	0.000487	CcSEcCtD
Pilocarpine—CHRM2—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	9.58e-05	0.00256	CbGpPWpGaD
Pilocarpine—CYP2A6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	9.54e-05	0.00255	CbGpPWpGaD
Pilocarpine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	9.53e-05	0.00254	CbGpPWpGaD
Pilocarpine—Anorexia—Prednisone—chronic obstructive pulmonary disease	9.52e-05	0.00048	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	9.1e-05	0.000459	CcSEcCtD
Pilocarpine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	9.09e-05	0.000458	CcSEcCtD
Pilocarpine—CYP2A6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.05e-05	0.00242	CbGpPWpGaD
Pilocarpine—Insomnia—Prednisone—chronic obstructive pulmonary disease	9.03e-05	0.000455	CcSEcCtD
Pilocarpine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	8.97e-05	0.000452	CcSEcCtD
Pilocarpine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	8.79e-05	0.000443	CcSEcCtD
Pilocarpine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	8.68e-05	0.000437	CcSEcCtD
Pilocarpine—Rash—Prednisolone—chronic obstructive pulmonary disease	8.66e-05	0.000437	CcSEcCtD
Pilocarpine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	8.66e-05	0.000436	CcSEcCtD
Pilocarpine—Headache—Prednisolone—chronic obstructive pulmonary disease	8.61e-05	0.000434	CcSEcCtD
Pilocarpine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	8.59e-05	0.00229	CbGpPWpGaD
Pilocarpine—Constipation—Prednisone—chronic obstructive pulmonary disease	8.54e-05	0.00043	CcSEcCtD
Pilocarpine—CHRM1—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	8.5e-05	0.00227	CbGpPWpGaD
Pilocarpine—CHRM2—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	8.48e-05	0.00226	CbGpPWpGaD
Pilocarpine—CHRM3—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	8.47e-05	0.00226	CbGpPWpGaD
Pilocarpine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	8.23e-05	0.000415	CcSEcCtD
Pilocarpine—CYP2E1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.21e-05	0.00219	CbGpPWpGaD
Pilocarpine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	8.17e-05	0.000412	CcSEcCtD
Pilocarpine—Nausea—Prednisolone—chronic obstructive pulmonary disease	8.16e-05	0.000411	CcSEcCtD
Pilocarpine—CYP2E1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.09e-05	0.00216	CbGpPWpGaD
Pilocarpine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	7.89e-05	0.000398	CcSEcCtD
Pilocarpine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	7.89e-05	0.000398	CcSEcCtD
Pilocarpine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.7e-05	0.00206	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	7.64e-05	0.00204	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	7.62e-05	0.00203	CbGpPWpGaD
Pilocarpine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7.6e-05	0.00203	CbGpPWpGaD
Pilocarpine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	7.6e-05	0.00203	CbGpPWpGaD
Pilocarpine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	7.57e-05	0.00202	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	7.55e-05	0.00201	CbGpPWpGaD
Pilocarpine—CYP2E1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.54e-05	0.00201	CbGpPWpGaD
Pilocarpine—CYP2E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.44e-05	0.00199	CbGpPWpGaD
Pilocarpine—CHRM1—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	7.43e-05	0.00198	CbGpPWpGaD
Pilocarpine—CHRM3—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	7.41e-05	0.00198	CbGpPWpGaD
Pilocarpine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	7.36e-05	0.000371	CcSEcCtD
Pilocarpine—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	7.35e-05	0.00196	CbGpPWpGaD
Pilocarpine—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	7.33e-05	0.00196	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—APIP—chronic obstructive pulmonary disease	7.28e-05	0.00194	CbGpPWpGaD
Pilocarpine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	7.25e-05	0.00194	CbGpPWpGaD
Pilocarpine—Asthenia—Prednisone—chronic obstructive pulmonary disease	7.16e-05	0.000361	CcSEcCtD
Pilocarpine—CYP2E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.15e-05	0.00191	CbGpPWpGaD
Pilocarpine—Pruritus—Prednisone—chronic obstructive pulmonary disease	7.06e-05	0.000356	CcSEcCtD
Pilocarpine—CYP2E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.05e-05	0.00188	CbGpPWpGaD
Pilocarpine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	6.83e-05	0.000344	CcSEcCtD
Pilocarpine—CHRM3—Metabolism—APIP—chronic obstructive pulmonary disease	6.83e-05	0.00182	CbGpPWpGaD
Pilocarpine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	6.65e-05	0.00178	CbGpPWpGaD
Pilocarpine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	6.63e-05	0.00177	CbGpPWpGaD
Pilocarpine—Dizziness—Prednisone—chronic obstructive pulmonary disease	6.6e-05	0.000333	CcSEcCtD
Pilocarpine—CHRM1—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	6.52e-05	0.00174	CbGpPWpGaD
Pilocarpine—Vomiting—Prednisone—chronic obstructive pulmonary disease	6.35e-05	0.00032	CcSEcCtD
Pilocarpine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	6.3e-05	0.00168	CbGpPWpGaD
Pilocarpine—Rash—Prednisone—chronic obstructive pulmonary disease	6.3e-05	0.000317	CcSEcCtD
Pilocarpine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	6.29e-05	0.000317	CcSEcCtD
Pilocarpine—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	6.28e-05	0.00168	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	6.26e-05	0.00167	CbGpPWpGaD
Pilocarpine—Headache—Prednisone—chronic obstructive pulmonary disease	6.26e-05	0.000315	CcSEcCtD
Pilocarpine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.24e-05	0.00167	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	6.24e-05	0.00167	CbGpPWpGaD
Pilocarpine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	6.22e-05	0.00166	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	6.18e-05	0.00165	CbGpPWpGaD
Pilocarpine—CHRM1—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	6.08e-05	0.00162	CbGpPWpGaD
Pilocarpine—Nausea—Prednisone—chronic obstructive pulmonary disease	5.93e-05	0.000299	CcSEcCtD
Pilocarpine—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	5.75e-05	0.00154	CbGpPWpGaD
Pilocarpine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	5.75e-05	0.00153	CbGpPWpGaD
Pilocarpine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	5.73e-05	0.00153	CbGpPWpGaD
Pilocarpine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	5.67e-05	0.00151	CbGpPWpGaD
Pilocarpine—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	5.63e-05	0.0015	CbGpPWpGaD
Pilocarpine—CHRM3—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	5.61e-05	0.0015	CbGpPWpGaD
Pilocarpine—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	5.55e-05	0.00148	CbGpPWpGaD
Pilocarpine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.49e-05	0.00147	CbGpPWpGaD
Pilocarpine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.43e-05	0.00145	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	5.36e-05	0.00143	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	5.34e-05	0.00143	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	5.29e-05	0.00141	CbGpPWpGaD
Pilocarpine—CHRM2—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	5.24e-05	0.0014	CbGpPWpGaD
Pilocarpine—CHRM1—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	5.12e-05	0.00137	CbGpPWpGaD
Pilocarpine—CHRM2—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	5.03e-05	0.00134	CbGpPWpGaD
Pilocarpine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	4.92e-05	0.00131	CbGpPWpGaD
Pilocarpine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	4.91e-05	0.00131	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	4.87e-05	0.0013	CbGpPWpGaD
Pilocarpine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	4.86e-05	0.0013	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	4.85e-05	0.0013	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.82e-05	0.00129	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	4.8e-05	0.00128	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	4.8e-05	0.00128	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	4.78e-05	0.00128	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	4.73e-05	0.00126	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—GC—chronic obstructive pulmonary disease	4.69e-05	0.00125	CbGpPWpGaD
Pilocarpine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.57e-05	0.00122	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.52e-05	0.00121	CbGpPWpGaD
Pilocarpine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.5e-05	0.0012	CbGpPWpGaD
Pilocarpine—CYP2A6—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	4.43e-05	0.00118	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—GC—chronic obstructive pulmonary disease	4.4e-05	0.00117	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.36e-05	0.00116	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	4.32e-05	0.00115	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	4.31e-05	0.00115	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	4.28e-05	0.00114	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	4.27e-05	0.00114	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	4.26e-05	0.00114	CbGpPWpGaD
Pilocarpine—CHRM2—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	4.26e-05	0.00114	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	4.23e-05	0.00113	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.09e-05	0.00109	CbGpPWpGaD
Pilocarpine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	4.03e-05	0.00107	CbGpPWpGaD
Pilocarpine—CHRM3—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	4.01e-05	0.00107	CbGpPWpGaD
Pilocarpine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	3.97e-05	0.00106	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.92e-05	0.00105	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.91e-05	0.00104	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.87e-05	0.00103	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.81e-05	0.00102	CbGpPWpGaD
Pilocarpine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.81e-05	0.00102	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.79e-05	0.00101	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.78e-05	0.00101	CbGpPWpGaD
Pilocarpine—CHRM2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	3.78e-05	0.00101	CbGpPWpGaD
Pilocarpine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.76e-05	0.001	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	3.75e-05	0.001	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.74e-05	0.001	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	3.74e-05	0.000998	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	3.71e-05	0.00099	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	3.7e-05	0.000988	CbGpPWpGaD
Pilocarpine—CHRM2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	3.65e-05	0.000974	CbGpPWpGaD
Pilocarpine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.5e-05	0.000934	CbGpPWpGaD
Pilocarpine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.45e-05	0.000921	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.45e-05	0.00092	CbGpPWpGaD
Pilocarpine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.32e-05	0.000886	CbGpPWpGaD
Pilocarpine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.27e-05	0.000874	CbGpPWpGaD
Pilocarpine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.04e-05	0.000812	CbGpPWpGaD
Pilocarpine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.03e-05	0.000809	CbGpPWpGaD
Pilocarpine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3e-05	0.000802	CbGpPWpGaD
Pilocarpine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	3e-05	0.000802	CbGpPWpGaD
Pilocarpine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	2.99e-05	0.000799	CbGpPWpGaD
Pilocarpine—CHRM2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	2.94e-05	0.000786	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.87e-05	0.000768	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.87e-05	0.000765	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.84e-05	0.000758	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.71e-05	0.000724	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.7e-05	0.000721	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.67e-05	0.000714	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.67e-05	0.000713	CbGpPWpGaD
Pilocarpine—CHRM1—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	2.66e-05	0.00071	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.56e-05	0.000684	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—GCLC—chronic obstructive pulmonary disease	2.53e-05	0.000676	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.46e-05	0.000657	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.45e-05	0.000655	CbGpPWpGaD
Pilocarpine—CHRM1—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	2.43e-05	0.00065	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.43e-05	0.000649	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.42e-05	0.000647	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.41e-05	0.000645	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.4e-05	0.000642	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.39e-05	0.000638	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—GCLC—chronic obstructive pulmonary disease	2.38e-05	0.000634	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.32e-05	0.000619	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.32e-05	0.000618	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—CTGF—chronic obstructive pulmonary disease	2.31e-05	0.000617	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.31e-05	0.000617	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.31e-05	0.000616	CbGpPWpGaD
Pilocarpine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	2.31e-05	0.000616	CbGpPWpGaD
Pilocarpine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	2.3e-05	0.000614	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.29e-05	0.000611	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.29e-05	0.00061	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.2e-05	0.000587	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.19e-05	0.000585	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.17e-05	0.00058	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—CTGF—chronic obstructive pulmonary disease	2.17e-05	0.000579	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.13e-05	0.000569	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.12e-05	0.000566	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.11e-05	0.000564	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.09e-05	0.000558	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.02e-05	0.000541	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	2e-05	0.000534	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2e-05	0.000533	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.92e-05	0.000514	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.92e-05	0.000512	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.9e-05	0.000507	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.83e-05	0.000488	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.78e-05	0.000474	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.77e-05	0.000472	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.75e-05	0.000468	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.72e-05	0.000459	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.69e-05	0.000452	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.69e-05	0.000451	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.68e-05	0.000449	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.67e-05	0.000447	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.67e-05	0.000445	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.64e-05	0.000439	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.63e-05	0.000436	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.6e-05	0.000427	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.58e-05	0.000421	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.57e-05	0.000419	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.55e-05	0.000415	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.55e-05	0.000413	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.53e-05	0.000409	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.45e-05	0.000388	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.45e-05	0.000387	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.45e-05	0.000387	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.43e-05	0.000383	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.4e-05	0.000375	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.38e-05	0.00037	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.31e-05	0.000349	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.3e-05	0.000348	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.3e-05	0.000347	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.29e-05	0.000346	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.29e-05	0.000345	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.29e-05	0.000344	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.28e-05	0.000342	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.22e-05	0.000326	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.19e-05	0.000317	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.18e-05	0.000316	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.18e-05	0.000315	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.18e-05	0.000314	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.17e-05	0.000313	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.17e-05	0.000311	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.14e-05	0.000303	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.13e-05	0.000302	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.12e-05	0.0003	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.06e-05	0.000282	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.05e-05	0.000281	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—ALB—chronic obstructive pulmonary disease	1.05e-05	0.000281	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.04e-05	0.000278	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.01e-05	0.000269	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—ALB—chronic obstructive pulmonary disease	9.86e-06	0.000263	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—NOS3—chronic obstructive pulmonary disease	9.44e-06	0.000252	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.39e-06	0.000251	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	9.29e-06	0.000248	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.69e-06	0.000232	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.66e-06	0.000231	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.57e-06	0.000229	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	8.47e-06	0.000226	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	8.31e-06	0.000222	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.29e-06	0.000221	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.26e-06	0.000221	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.18e-06	0.000219	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	7.95e-06	0.000212	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.91e-06	0.000211	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.89e-06	0.000211	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.81e-06	0.000209	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.81e-06	0.000208	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.02e-06	0.000187	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7e-06	0.000187	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.93e-06	0.000185	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.68e-06	0.000178	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.65e-06	0.000178	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.59e-06	0.000176	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.51e-06	0.000174	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.42e-06	0.000171	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.35e-06	0.00017	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.33e-06	0.000169	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.27e-06	0.000167	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.98e-06	0.00016	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.7e-06	0.000152	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.68e-06	0.000152	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.67e-06	0.000151	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.63e-06	0.00015	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.23e-06	0.00014	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.22e-06	0.000139	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.17e-06	0.000138	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.13e-06	0.000137	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.12e-06	0.000137	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.07e-06	0.000135	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.31e-06	0.000115	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.29e-06	0.000115	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.25e-06	0.000114	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.94e-06	0.000105	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.93e-06	0.000105	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.89e-06	0.000104	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.86e-06	0.000103	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.69e-06	9.85e-05	CbGpPWpGaD
